GPX4 and cancer: SLC7A11 inhibition, cysteine deprivation, or targeting GPX4 have been reported to effectively enhance lipid peroxidation and induce ferroptosis in several cancer types (Dixon et al., 2012; Badgley et al., 2020; Shi et al., 2021; Yang et al., 2023).